Business Description
Neumora Therapeutics is a US-based drug development company focused on finding new treatments for mental health and brain disorders, including depression, Alzheimer's disease, schizophrenia, Parkinson's disease, and ALS. Its most advanced drug candidate is navacaprant, a once-daily oral pill currently in late-stage clinical trials for major depressive disorder. The company has several other treatments in earlier stages of testing and research. Founded in 2019 and based in Watertown, Massachusetts, Neumora was previously known as RBNC Therapeutics before rebranding in 2021.
